Advertisement

Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

Breaking the Cycle of Sleepless Nights

Sleeping Aid Market Set to Expand

    This is a preview of subscription content, log in to check access.

    Table 1
    Table 2
    Table 3

    References

    1. 1.

      Growing Awareness about the Seriousness of Insomnia Drives the Prescription Sleep Aid Market. Frost & Sullivan (2004).

    2. 2.

      Major Pharmaceuticals. Industry Overview. Neurology: physician panel discussion. Lehman Brothers Equity Research (2004).

    Download references

    Rights and permissions

    Reprints and Permissions

    About this article

    Cite this article

    Breaking the Cycle of Sleepless Nights. Pharmaceutical & Diagnostic Innovation 2, 3–7 (2004). https://doi.org/10.1007/BF03257297

    Download citation

    Keywords

    • Melatonin
    • Zolpidem
    • Zopiclone
    • Zaleplon
    • Sleep Onset Latency